Daily versus intermittent iron supplementation in pregnant women by Bouzari, Zinatossadat et al.
RESEARCH ARTICLE Open Access
Daily versus intermittent iron supplementation in
pregnant women
Zinatossadat Bouzari
1,2, Zahra Basirat
3, Mahtab Zeinal Zadeh
3, Shahla Yazdani Cherati
3,
Maryam Didehdar Ardebil
4,5, Maedeh Mohammadnetaj
6 and Shahnaz Barat
7*
Abstract
Background: The purpose of this study was compare of daily iron supplementation in three time frames- daily,
weekly and three time weekly supplementation in preventing anemia in healthy pregnant women.
Method: The present study was a prospective simply randomized clinical trial. During January 2006- January 2008,
150 healthy pregnant women without anemia, in their 16th week of pregnancy were randomly allocated into
three equal groups. The first group (n = 50) received a 50 mg-ferrous sulfate tablet daily, second group (n = 50)
received a 50 mg-ferrous sulfate tablet three times a week, and the third group (n = 50) received two 50 mg-
ferrous sulfate tablets (100 mg) weekly, respectively for 12 consecutive weeks. Serum hemoglobin, ferritin, and iron
were measured before and after the supplementation. Paired t and ANOVA tests were used as appropriated.
Results: There were no significant differences between the pre- and post-treatment hemoglobin levels with iron
supplementation in the three group (P = 0.518, P = 0.276, respectively). The mean serum iron level before and
after treatment with iron supplementation in the three groups was not statistically significant (P = 0.962, P = 0.970,
respectively). Although the mean serum ferritin level before and after treatment with iron supplementation was
statistically significant in the three groups, no significant differences were found comparing the three groups (P =
0.827, P = 0.635 respectively).
Conclusions: This results suggested, three times a week or weekly iron supplementation is as effective as daily
supplementation for healthy pregnant women without anemia.
Trial Registration: ISRCTN: IRCT201101093820N1
Background
Iron requirements increase during pregnancy [1,2]. And
this requirement may lead to anemia in pregnant women
[3,4]. Lower hemoglobin cut off is 11.0 g/dL in the first
and last trimester and 10.5 g/dL in the second trimester.
Therefore, any level below 10.5 g/dL should be considered
as anemia [5]. Iron consumption for pregnant women is
undesirable, because of the side effects. The probable
cause is the effect of oxidative stress of high doses of Iron,
which leads to gastrointestinal intolerance [3]. As gut
mucosal turnover rates is about three days, administering
iron during these days may lead to lower iron absorption.
Periodic iron supplementation may let the mucosa to heal
and gets better iron absorption [6-8]. Previous studies
reported, continuous administration of oral iron impairs
the absorption of a subsequent iron dose [9]. A few experi-
mental studies demonstrated that alternative efficacious
iron supplementation regimens might reduce the undesir-
able side-effects [10]. Significant equality and reduced side
effects have been reported in several epidemiological stu-
dies in comparing the weekly prescription of iron with
daily supplementation [3-7]. In the other studies, there
was not found difference between daily and twice-weekly
iron supplementation regimens in preventing iron defi-
ciency anemia in children, non-pregnant women, and
pregnant women in their early trimesters [12-14]. And in
another study, intermittent regimen was shown to be
superior to daily regimen [3-15]. In human beings, gut
mucosal turnover occurs every 3 days. Thus, weekly rather
than daily administration of iron has been proposed as a
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any medium, provided the original work is properly cited.safe, beneficent, and cost-effective method to prevent and
alleviate anemia in pregnant women [12-17]. As men-
tioned above there are different study which studied effect
of iron separately in daily use and weekly and three times.
Thus authors aimed to compare the effects of daily, three
times a week, and weekly iron supplementation regimens
on hematological markers in pregnant women without
anemia.
Methods
T h ep r e s e n ts t u d yw a sap r o s p e c t i v es i m p l yr a n d o m i z e d
clinical trial conducted during January 2006-January
2008 in six health centers affiliated to Babol University of
Medical Sciences northern Iran. The centers were
selected through a cluster randomization out of the 40
centers affiliated to the University. Serum hemoglobin
(Hycel cell counter, France), serum ferritin (radioimmu-
noassay technique, Genesis factory, USA), and serum
iron (Pars azmoon, Iran) levels were measured for all
pregnant women who attended the antenatal clinics in
their 14th week of gestation. Women with hemoglobin
levels less than 11 g/dL, chronic hematological disorders
(thalassemia, etc.), and multiple pregnancies were
excluded from the study.
Hundred fifty pregnant women without exclusion cri-
t e r i aw e r ee n r o l l e di nt h es t u d yi nt h e i r1 6t hw e e ko f
gestation. A written informed consent was obtained from
all the participants. The Ethics Committee of the Univer-
sity approved the study protocol. The women were
divided to three equal groups. All the groups were
matched in terms of age, numbers of pregnant, income,
and education. The first group (n = 50) received a 50
mg-ferrous sulfate tablet (Darou Pakhsh, Iran) daily, the
second group (n = 50) received a 50 mg-ferrous sulfate
tablet three times a week, and the third group (n = 50)
received two 50 mg-ferrous sulfate tablets (100 mg)
weekly, respectively.
Iron supplementation was prescribed in 16th week of
gestation and was continued according to the mentioned
regimens for 12 weeks (until 28th weeks of gestation).
Serum hemoglobin, serum ferritin, and serum iron levels
were measured for all the participants at the end of the
trial period. And patients who were diagnosed as having
anemia were treated according to the standard protocol.
Statistical analyses
Data were recorded on a pre-designed form. All of the
entries were checked twice. Collected data were ana-
lyzed using SPSS software version 13. Serum sample
levels of hemoglobin, iron, and ferritin before and after
treatment were evaluated using paired t test. ANOVA
was used to compare the mean values of serum hemo-
globin, ferritin, and iron between the three groups. P
value<0.05 considered as statistically significant.
Results
Totally 150 participate, enrolled in the study, among total
sample eight women were excluded because of abortion,
premature labor, and immigration. Therefore the study
continued with 50 pregnant women in daily regimen, 43
in three-time a week regimen, and 49 in weekly regimen
groups. There were not reported any side effects related to
iron consumption such as nausea, vomiting, and bowel
disturbances.
Serum levels of hemoglobin, iron, and ferritin before
and after treatment in the three supplementation regi-
mens are shown in (Table 1).
According to Table 1, the mean serum hemoglobin and
ferritin levels were statistically different in the first and
third groups but in the second group only ferritin level
changes was significant. There were no significant differ-
ences between the serum hemoglobin levels before and
after supplementation with iron in the three group (P =
0.518, P = 0.276, respectively, (Table 2).
The mean serum iron level before and after supple-
mentation with iron in the three groups was
not statistically significant (P = 0.962, P = 0.970,
respectively, (Table 2) Although the mean serum ferritin
level before and after supplementation with iron was sta-
tistically significant in the three groups, no significant dif-
ferences were found comparing the three groups (P =
0.827, P = 0.635 respectively, (Table 2).
Discussion
In the current study, Authors found daily, three times a
week, and weekly iron supplementation regimens were
comparably effective in pregnant women without anemia.
Serum ferritin and hemoglobin levels decreased after 12
weeks of supplementation. Serum ferritin decreased after
supplementation with all three regimens. Because of more
iron need during that period. However such decrease was
not statistically significant.
Mukhopadhyay and colleagues compared daily con-
sumption of 100 mg elemental iron (n = 55) with weekly
consumption of 200 mg elemental iron (n = 56) in India.
They found no significant difference in serum hemoglobin
levels after 17 weeks of supplementation between their
two groups [3]. In another study in Indonesia, Muslimatun
and colleagues compared the effects of daily prescription
of 60 mg elemental iron (n = 123) with weekly prescrip-
tion of 120 mg elemental iron (n = 122) in preventing iron
deficiency anemia. No significant difference was observed
between the groups and the authors concluded that
weekly supplementation of iro nw a sa se f f e c t i v ea sd a i l y
supplementation in preventing anemia in pregnant
women [11]. In the study by Haidar in Ethiopia, weekly
iron supplementation was as effective as daily regimen in
preventing anemia in breast feeding women [19]. In
another study in Mexico by Casanueva and co-workers to
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Page 2 of 5Table 1 Serum levels of hemoglobin, iron, and ferritin before and after the three supplementation regimens
Daily (n = 50) P value Three-time a week (n = 43) P value Weekly (n = 49) P value
Hemoglobin(g/dL, mean ± SD) Before supplementation 12/44 ± 0/99 P<0/001* 12/62 ± 0/78 P = 0/541 12/53 ± 0/77 P<0/001*
After supplementation 11/084 ± 0/82 14/03 ± 14/68 11/62 ± 0/82
Serum iron (μg/dl, mean ± SD) Before supplementation 96/74 ± 34/31 P = 0/948 94/21 ± 31/14 P = 0/516 97/28 ± 31/65 P = 0/942
After supplementation 97/14 ± 40/06 99/90 ± 53/33 96/57 ± 62/62
Serum ferritin (μg/L, mean ± SD) Before supplementation 59/66 ± 45/32 P = 0/005* 58/82 ± 33/6 P = 0/00* 56/53 ± 33/33 P = 0/002*
After supplementation 39/90 ± 4/51 32/86 ± 32/78 37/87 ± 34/95
B
o
u
z
a
r
i
e
t
a
l
.
B
M
C
R
e
s
e
a
r
c
h
N
o
t
e
s
2
0
1
1
,
4
:
4
4
4
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
7
5
6
-
0
5
0
0
/
4
/
4
4
4
P
a
g
e
3
o
f
5compare the daily prescription of 60 mg elemental iron
(n = 56) with weekly prescription of 120 mg elemental
iron, both regimens were equally effective in preventing
anemia in pregnancy. Our findings are in line with these
studies [16]. In similar studies by Young and others in
rural areas of Malawi and by Galloway and colleagues,
60 mg daily regimens were as effective as 120 mg weekly
regimens for preventing anemia [18-20]. And similar to
our study, serum hemoglobin levels were not different
after 8 weeks of treatment.
In a randomized clinical trial in 2001, Goonewarden
and co-workers compared the effects of daily (n = 31),
three times a week (n = 35), and weekly (n = 26) pre-
scription of 100 mg elemental iron. They measured
serum hemoglobin, hematocrit, and ferritin before and
after the intervention and stated that the risk of develop-
ment of iron deficiency anemia was significantly higher
in three times a week and weekly supplementation of
iron compared with daily regimen [21]. These findings
contrast with our results. The reason may be the smaller
sample size, and differences in race and nutritional habits
of the participants in Goonewarden’s study. Mumtaz and
others showed in a clinical trial that daily iron supple-
mentation was more effective than weekly supplementa-
tion in Pakistani pregnant women. They randomly
assigned 191 pregnant women with anemia (Hgb<11 g/
dl) to two groups. One group received 200 mg elemental
iron daily and the other group received 400 mg elemental
iron twice a week. Serum hemoglobin increased signifi-
cantly in women receiving daily iron supplementation.
Moreover, serum ferritin was elevated only in the daily
regimen [15]. The variation observed in this study can be
attributed to the fact that Mumtaz and colleagues studied
women who already had anemia before pregnancy. Addi-
tionally, racial, geographical, and nutritional factors could
be responsible for the differences observed.
Conclusion
Our study demonstrated all of three regimens of iron
supplementation; daily, three times a week and weekly
are effective for prevention of anemia during pregnancy
in pregnant women without anemia. Therefore, results
suggested health care providers adapt weekly regimens
because of the better patients’ compliance. This finding
c a np a r t l yb ee x p l a i n e db yt h ee x p a n s i o no fp l a s m a
volume and increased need to Iron by the fetus, which
usually occur in the second trimester of pregnancy.
Although iron supplementation by all three regimens
could not change the level to normal, it could prevent
further iron deficiency anemia.
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